Total Funding
26
50
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57512
Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Stephanie O'Brien: Director- Larry Altstiel: Chief Medical Officer
About the Company
Pinteon Therapeutics focuses on the discovery and development of breakthrough therapeutics targeting Pin1. Pin1 acts as a central regulator in cancer development and growth as well as a number of other disease areas including CNS and autoimmune diseases. By inhibiting or activating Pin1, Pinteon will normalize aberrant disease processes and
improve patient outcomes in these high unmet medical need indications.
Pinteon Therapeutics was founded in 2014 and is headquartered in Newton, Massachusetts.
